The adoption of magnesium trisilicate in the pharmaceutical industry is expected to aid in the growth of the pharma-grade magnesium trisilicate market. Magnesium trisilicate is an antacid having a pH of 7.4. It is formulated from the metal magnesium and silica salts using a process of dehydration and is employed in the manufacture of a variety of pharmaceuticals and nutritive substances. Magnesium trisilicate is an inorganic compound that is used as a food additive.
The high prevalence of dyspepsia is expected to aid in the growth of the pharma-grade magnesium trisilicate market. Magnesium trisilicate is one of many salts of magnesium used clinically for the relief of the symptoms of dyspepsia. Common clinical manifestations associated with deficiency of magnesium trisilicate are abdominal pain, nausea, loss of appetite, weakness, dry mouth, abdominal bloating, constipation, and abnormal heartbeat. Abnormal heartbeat caused by deficiency of magnesium trisilicate can cause chest pain and rapid, irregular heartbeat. Abnormal chest pain suggests a problem in the portal vein or the umbilical cord. The abnormal heartbeat may be accompanied by dyspnea, fever, night sweats, and jaundice.
Side effects from regular use of magnesium trisilicate are expected to hinder the growth of the pharma-grade magnesium trisilicate market. There are other gastrointestinal side effects associated with the regular use of magnesium trisilicate, including stomach ulcers and a decrease in appetite. The exact reason for these side effects is unknown and may be due to the low absorption rate and low solubility of magnesium trisilicate. It is advisable to obtain medical advice before starting to take magnesium trisilicate, especially if one has a history of allergic reactions to silicon dioxide or nitrates contained in other medications.... Read more